25-hydroxycholesterol 3-sulfate: Clinical Trials

1 trial of 25-hydroxycholesterol 3-sulfate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow 25-hydroxycholesterol 3-sulfate: new trials by email Literature Review of 25-hydroxycholesterol 3-sulfate trials Research Report on 25-hydroxycholesterol 3-sulfate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DUR-928 in Patients With Alcoholic Hepatitis
DUR-928 (Moderate AH), DUR-928 (Severe AH) - Alcoholic Hepatitis
Phase 2CompletedCraig James McClain432021-06-012023-10-18

Conditions studied

Hepatitis, Alcoholic (1)  ·  Liver Diseases, Alcoholic (1)

Sponsors

Craig James McClain (1)

Countries

United States (1)

Top investigators

Craig J McClain, M.D. (1)  ·  Vatsalya Vatsalya, M.D. (1)

Results publications

PMID 11605686, PMID 15763232, PMID 21085006, PMID 23855300, PMID 25901427

NIH funding

U01AA026934 (1)